Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.48 |
| ▸ | CA1 | P00915 | 4/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA7 | P43166 | 4/20 | 0.48 |
| ▸ | CA9 | Q16790 | 4/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.48 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | XDH | P47989 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22828496 | 0.90 | CA1 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL21821501 | 0.83 | LMNA (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL402038 | 0.83 | KDM4E (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29853860 | 0.83 | LMNA (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30003562 | 0.83 | CA12 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27091761 | 0.83 | CA12 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8779293 | 0.81 | CA12 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL21821414 | 0.81 | MAPT (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30808280 | 0.81 | MAPT (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL22445927 | 0.81 | CA12 (0.48) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1293495-B1 | PROCESS FOR THE PREPARATION OF BROMOISOPHTHALIC ACID COMPOUNDS | NISSAN CHEMICAL IND LTD (JP) | 2013-04-24 | — | — | EP | disclosed |
| US-6855845-B2 | Process for the preparing bromoisophithalic acid compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-02-15 | — | — | US | disclosed |
| US-20040015010-A1 | Process for the preparation of bromoisophthalic acid compounds | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2004-01-22 | — | — | US | disclosed |
| EP-1293495-A1 | PROCESS FOR THE PREPARATION OF BROMOISOPHTHALIC ACID COMPOUNDS | Nissan Chemical Industries, Ltd. (JP) | 2003-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040015010-A1 | Process for the preparation of bromoisophthalic acid compounds | CYP2F1, SULT1E1, SULT1A1 | CA12 1501/4885CA1 273/4885CA2 800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.